Skip to main content
European Commission logo
Enterprise Europe Network

Swiss-based company offering innovative software solutions to ensure data integrity and security for valuable clinical trial data by leveraging blockchain technology looks for commercial agreement

Summary

Profile Type
Business Offer
POD Reference
BOCH20240403003
Term of Validity
1 May 2024 - 1 May 2025
Company's Country
Switzerland
Type of partnership
Commercial agreement
Targeted Countries
All countries
Contact the EEN partner nearest to you for more information.
Find my local partner

General information

Short Summary
The Swiss tech company offers advanced software solutions for global clinical research (i.e. eConsent, eCOA). The platform serves biotech, pharma, medtech and research institutions, streamlining clinical trials, enhancing data integrity and security, and boosting research outcomes. It simplifies workflows and accelerates therapy development. The company is seeking for commercial agreement with early adopters of their innovative solution to use synergies and improve their product portfolio.
Full Description
Revolutionizing Clinical Research Data Capture Through Advanced Clinical Trial Software

The company is setting new standards in the field of data capture for clinical research. Their state-of-the-art software solutions are designed to meet the complex demands of today’s biotech/ medtech companies, pharmaceutical organizations, and research institutions across the globe. With a focus on user-friendliness and technical superiority, the company is dedicated to enhancing the integrity and security of clinical trials.

Technical Aspects
The company´s product is a blockchain based platform with modular software solutions to facilitate the conduct of clinical trials in all kinds of settings (fully decentralized trials, hybrid trials or on-site trial settings), supporting both small-scale trials and global multi-center trials.
The current product portfolio includes a mobile application for patients and web-based applications for clinical trial sites with the following modules available:
- eConsent, which lets participants read and sign informed consent documents online (can be used on a global scale with or without eSignatures)
- electronic Clinical Outcomes Assessments (questionnaires, daily diaries, etc.)
The trial participants are able to download the app from the app stores, thus can use their own devices from the comfort of their home. The clinical trials site use a web-based application. The sponsor have an administrative module and reportings/Dashboard available to ensure proper oversight.
Moreover, the sponsor can create customized forms with the designer application and use these to create questionnaire, consent forms etc. and build up a re-usable library.
An eCRF (electronic case report form) system is currently in development. The company would like to use synergies with potential partners and enlarge/improve their product portfolio.

The Swiss company is looking for commercial agreement with medical device or MedTech companies, biotech companies, pharma companies, contract research organizations, & universities/academia
Advantages and Innovations
The foundation of the software platform is based on blockchain technology. Legacy systems are lacking in securing valuable clinical trial data by e.g. storage on local servers and are an easy target for data steals, data losses or data tampering.
Blockchain technology provides 2 major advantages in comparison to legacy systems:
1. Data security: By storing the same copy of the datasets across a network of servers that are interconnected to each other, data loss is prevented.
2. Data integrity: Data cannot be hacked, thus you can secure your study data and your audit trail at the highest standard and are trusted by the regulatory agencies.
Stage of Development
Already on the market
Sustainable Development Goals
Goal 9: Industry, Innovation and InfrastructureGoal 3: Good Health and Well-being

Partner Sought

Expected Role of a Partner
Medical Device or MedTech companies
Biotech companies
Pharma
CROs
Universities/academia

The specific area of activity of the partner:clinical trials/ medical research

The tasks to be performed by the partner sought:
Commercial collaboration – use and improvement of the software suite
Type and Size of Partner
OtherSME 11-49UniversitySME 50 - 249R&D InstitutionSME <=10
Type of partnership
Commercial agreement

Call details

Coordinator required
Yes

Dissemination

Technology keywords
06001015 - Pharmaceutical Products / Drugs06001002 - Clinical Research, Trials01004001 - Applications for Health06001012 - Medical Research01003013 - Information Technology/Informatics
Market keywords
05005022 - Other clinical medicine05005017 - Dentistry / Odontology, Stomatology02007012 - Medical/health software02007022 - Software services
Sector Groups Involved
Health
Targeted countries
All countries

Images